Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

Onco Targets Ther · 2020 · PMC7381816 · PMID 32764990

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

After the 13th day, the tumors in the left lower limb of the CpG+4-1BB group showed a trend of regression, and the volume measured on the 29th day was only 47.25±0.93 mm 3 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.